scholarly article | Q13442814 |
P356 | DOI | 10.1053/PLAC.2002.0953 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0143400402909537?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:S0143400402909537?httpAccept=text/xml | ||
P698 | PubMed publication ID | 12744929 |
P2093 | author name string | T. M. Mayhew | |
C. Sampson | |||
P2860 | cites work | Pregnancy complicating diabetes | Q28284159 |
Denudations as paracellular routes for alphafetoprotein and creatinine across the human syncytiotrophoblast | Q30845427 | ||
Diabetes epidemiology as a tool to trigger diabetes research and care | Q33638290 | ||
Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome | Q33916231 | ||
The volumetric composition of human term placentae: altitudinal, ethnic and sex differences in Bolivia | Q34090739 | ||
Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts | Q34123183 | ||
Pathophysiology of oxidative stress in diabetes mellitus | Q34310277 | ||
Villous trophoblast of human placenta: a coherent view of its turnover, repair and contributions to villous development and maturation | Q34408495 | ||
Trophoblast interaction with fibrin matrix. Epithelialization of perivillous fibrin deposits as a mechanism for villous repair in the human placenta | Q35811891 | ||
Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study | Q36245629 | ||
Apoptotic changes occur in syncytiotrophoblast of human placental villi where fibrin type fibrinoid is deposited at discontinuities in the villous trophoblast | Q36830490 | ||
Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus | Q37066210 | ||
The fibrinolytic system in diabetes mellitus | Q37124843 | ||
Inhibitors of fibrinolysis in diabetic children, mothers, and their newborn | Q39593992 | ||
Nonenzymatic Glycosylation Reduces the Susceptibility of Fibrin to Degradation by Plasmin | Q72787738 | ||
Quantitative aspects of placental structure | Q72858440 | ||
Stereological comparison of 3D spatial relationships involving villi and intervillous pores in human placentas from control and diabetic pregnancies | Q73003843 | ||
Antiphosphatidylserine antibody removes annexin-V and facilitates the binding of prothrombin at the surface of a choriocarcinoma model of trophoblast differentiation | Q73880666 | ||
A stereological method for testing whether or not there is random deposition of perivillous fibrin-type fibrinoid at the villous surface: description and pilot applications to term placentae | Q74312106 | ||
Immuno-electron microscopic localization of endothelial nitric oxide synthase in human placental terminal villous trophoblasts-normal and pre-eclamptic pregnancy | Q74612817 | ||
Impact of diabetes-associated lipoproteins on generation of fibrinolytic regulators from vascular endothelial cells | Q77481508 | ||
Inverse relationship between apoptosis and Bcl-2 expression in syncytiotrophoblast and fibrin-type fibrinoid in early gestation | Q77763602 | ||
Etiology and pathophysiology of gestational diabetes mellitus | Q39820414 | ||
The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium | Q40103726 | ||
Diabetes as an atherogenic factor. | Q40176087 | ||
Villous trophoblast: morphometric perspectives on growth, differentiation, turnover and deposition of fibrin-type fibrinoid during gestation | Q40691558 | ||
Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects | Q40795448 | ||
Some chemical indices of diabetic vascular disease | Q41244222 | ||
The fibrinoids of the human placenta: origin, composition and functional relevance. | Q41331763 | ||
Is there a physiological intravascular coagulation in obstetrical cases? | Q41433730 | ||
Histomorphometry of the human placenta in Class C diabetes mellitus | Q41497669 | ||
Fibrinogen and diabetes mellitus: is it time for intervention trials? | Q41531053 | ||
The influence of pregnancy upon blood coagulation and plasma fibrinolytic enzyme function | Q41719101 | ||
Immunohistochemical identification of the receptor for urokinase plasminogen activator associated with fibrin deposition in normal and ectopic human placenta | Q42462623 | ||
Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta. | Q42472477 | ||
Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria. | Q44012882 | ||
Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus | Q44553205 | ||
Reassessment of White's classification and Pedersen's prognostically bad signs of diabetic pregnancies in insulin-dependent diabetic pregnancies | Q44669634 | ||
Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy | Q47176184 | ||
Quantitative studies on the villi, trophoblast and intervillous pores of placentae from women with well-controlled diabetes mellitus | Q47702644 | ||
BCL-2 expression in the human placenta and its correlation with fibrin deposits | Q47750468 | ||
Quantitative studies of human placenta. I. Morphometry | Q47926050 | ||
Increase in expression and activity of thrombomodulin in term human syncytiotrophoblast microvilli. | Q47930335 | ||
The relationship between plasminogen activator inhibitor-1 and insulin resistance in newly diagnosed type 2 diabetes mellitus. | Q51599447 | ||
Fibrin generation during the diabetic pregnancy. | Q51644147 | ||
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. | Q53751216 | ||
Hypobaric hypoxia and villous trophoblast: evidence that human pregnancy at high altitude (3600 m) perturbs epithelial turnover and coagulation-fibrinolysis in the intervillous space | Q57110911 | ||
Impaired fibrinolytic response to exercise in type II diabetes: Effects of exercise and physical training | Q58108521 | ||
Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites | Q59663108 | ||
Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies | Q61929887 | ||
Coagulation and fibrinolysis parameters in normal pregnancy and in gestational diabetes | Q61971143 | ||
Plasma Cofactors of Platelet Function: Correlation with Diabetic Retinopathy and Hemoglobins Ala-c | Q66876851 | ||
Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes | Q67574961 | ||
Relationship of microvascular disease in diabetes to metabolic control | Q67599756 | ||
Thrombin clottable determination of plasma fibrinogen in pregnancy | Q67750821 | ||
Blood coagulation and fibrinolysis during normal pregnancy | Q67990317 | ||
Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus | Q68354986 | ||
Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery | Q68530681 | ||
Fibrinolysis and plasminogen levels in pregnancy and the puerperium | Q70059653 | ||
Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles. Pittsburgh Epidemiology of Diabetes Complications Study-V | Q70220095 | ||
Histological changes in placental syncytiotrophoblasts of poorly controlled gestational diabetic patients | Q70803654 | ||
Histomorphometry of the placenta of the diabetic woman: Class A diabetes mellitus | Q70922443 | ||
The fluid phase of coagulation and the accelerated atherosclerosis of diabetes mellitus | Q70973565 | ||
Coagulation and fibrinolysis in smoking and nonsmoking pregnant women | Q71406668 | ||
Quantitative structure of the normal human placenta from 10 weeks of gestation to term | Q71426121 | ||
Platelet adhesiveness, plasma fibrinogen and factor VIII levels in diabetes mellitus | Q71524902 | ||
Immunohistochemistry of two different types of placental fibrinoid | Q71658998 | ||
Histomorphometry of the human placenta in Class B diabetes mellitus | Q71749132 | ||
Perivillous fibrin deposition in the human placenta | Q72217304 | ||
Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion | Q72361563 | ||
The expression of the placental anticoagulant protein, annexin V, by villous trophoblasts: immunolocalization and in vitro regulation | Q72416328 | ||
Growth and maturation of villi in placentae from well-controlled diabetic women | Q72530284 | ||
Oxygen diffusive conductance in placentae from control and diabetic women | Q72616700 | ||
Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysis | Q72736003 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 524-531 | |
P577 | publication date | 2003-05-01 | |
P1433 | published in | Placenta | Q7200288 |
P1476 | title | Maternal diabetes mellitus is associated with altered deposition of fibrin-type fibrinoid at the villous surface in term placentae | |
Maternal Diabetes Mellitus is Associated with Altered Deposition of Fibrin-type Fibrinoid at the Villous Surface in Term Placentae | |||
P478 | volume | 24 |
Q80676339 | Distribution of the glycoconjugate oligosaccharides in the human placenta from pregnancies complicated by altered glycemia: lectin histochemistry |
Q38603046 | Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities. |
Q92164555 | Platelet-derived factors impair placental chorionic gonadotropin beta-subunit synthesis |
Q80031211 | Stereological analysis of mature human placenta of pregnant women of different age |
Search more.